BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21468923)

  • 21. Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites.
    Rodopoulos N; Norman A
    Scand J Clin Lab Invest; 1996 May; 56(3):259-68. PubMed ID: 8761530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
    Backman JT; Granfors MT; Neuvonen PJ
    Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide.
    Hu CP; Xiao L; Deng HW; Li YJ
    Planta Med; 2003 Feb; 69(2):125-9. PubMed ID: 12624816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine.
    Zhang FL; He X; Zhai YR; He LN; Zhang SC; Wang LL; Yang AH; An LJ
    Xenobiotica; 2015; 45(11):978-89. PubMed ID: 26053557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios.
    McNamara PJ; Burgio D; Yoo SD
    Drug Metab Dispos; 1992; 20(2):302-8. PubMed ID: 1352225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
    Peck K; Mealey KL; Matthews NS; Taylor TS
    Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of pharmacokinetic interaction of aphobazole with CYP1A2 drug-substrate in experiments].
    Novitskaia IaG; Litvin AA; Viglinskaia AO; Zherdev VP
    Eksp Klin Farmakol; 2013; 76(6):30-3. PubMed ID: 24003488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa.
    Ueng YF; Wang JJ; Lin LC; Park SS; Chen CF
    Life Sci; 2001 Nov; 70(2):207-17. PubMed ID: 11787945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.
    Bista SR; Lee SK; Thapa D; Kang MJ; Seo YM; Kim JH; Kim DH; Jahng Y; Kim JA; Jeong TC
    Toxicol Res; 2008 Sep; 24(3):195-199. PubMed ID: 32038795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
    Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
    Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and characterization of the metabolites of rutaecarpine in rats based on ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer.
    Cai W; Guan Y; Zhou Y; Wang Y; Ji H; Liu Z
    Pharm Biol; 2017 Dec; 55(1):294-298. PubMed ID: 27927077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1).
    Chen Z; Hu G; Li D; Chen J; Li Y; Zhou H; Xie Y
    Bioorg Med Chem; 2009 Mar; 17(6):2351-9. PubMed ID: 19254847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium.
    Han EH; Kim HG; Im JH; Jeong TC; Jeong HG
    Toxicology; 2009 Dec; 266(1-3):38-47. PubMed ID: 19853001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of caffeine in the oestrogen-implanted ovariectomized ewe.
    Pollard I; Williamson S; Downing J; Scaramuzzi R
    J Vet Pharmacol Ther; 1996 Apr; 19(2):113-7. PubMed ID: 8735418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.
    Wilkinson JM; Pollard I
    Brain Res Dev Brain Res; 1993 Oct; 75(2):193-9. PubMed ID: 8261611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.